Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Oxazolazepam |
EINECS | N/A |
CAS No. | 24143-17-7 | Density | 1.37g/cm3 |
PSA | 45.06000 | LogP | 3.23690 |
Solubility | N/A | Melting Point |
187°C |
Formula | C18H17 Cl N2 O2 | Boiling Point | 495.8°C at 760 mmHg |
Molecular Weight | 328.798 | Flash Point | 253.7°C |
Transport Information | N/A | Appearance | N/A |
Safety | Moderately toxic by intraperitoneal route. Mildly toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of Cl− and NOx. | Risk Codes | 11-23/24/25-39/23/24/25-36/38-23/25 |
Molecular Structure | Hazard Symbols | F,T | |
Synonyms |
Hializan;Oxazolam; Oxazolazepam; Serenal; Serenal (Japanese); Tranquit |
Article Data | 15 |
IUPAC Name: 10-Chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
Synonyms of Oxazolazepam (CAS NO.24143-17-7) : 10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one ; Benzo(6,7)-1,4-diazepino-(5,4-b)-oxazol-6-one, 10-chloro-2,3,5,6,7,11b-hexahydro-2-methyl-11b-phenyl- ; Oxazolam ; Oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one, 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyl-
CAS NO: 24143-17-7
Molecular Formula:C18H17ClN2O2
Molecular Weight :328.79278
Molecular Structure :
EINECS: 246-032-0
Index of Refraction: 1.668
Surface Tension: 60.5 dyne/cm
Density: 1.37 g/cm3
Flash Point: 253.7 °C
Enthalpy of Vaporization: 76.34 kJ/mol
Boiling Point: 495.8 °C at 760 mmHg
Vapour Pressure: 5.71E-10 mmHg at 25°C
Oxazolazepam (CAS NO.24143-17-7) is used as intermediate in organic synthesis.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 768mg/kg (768mg/kg) | "Modern Pharmaceuticals of Japan, IV," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1972Vol. -, Pg. 91, 1972. | |
mouse | LD50 | oral | 5200mg/kg (5200mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 66, Pg. 107, 1970. | |
mouse | LD50 | subcutaneous | > 2gm/kg (2000mg/kg) | "Modern Pharmaceuticals of Japan, IV," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1972Vol. -, Pg. 91, 1972. | |
rat | LD50 | intraperitoneal | > 2gm/kg (2000mg/kg) | "Modern Pharmaceuticals of Japan, IV," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1972Vol. -, Pg. 91, 1972. | |
rat | LD50 | oral | > 4gm/kg (4000mg/kg) | "Modern Pharmaceuticals of Japan, IV," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1972Vol. -, Pg. 91, 1972. | |
rat | LD50 | subcutaneous | > 2gm/kg (2000mg/kg) | "Modern Pharmaceuticals of Japan, IV," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1972Vol. -, Pg. 91, 1972. |
Moderately toxic by intraperitoneal route. Mildly toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When Oxazolazepam (CAS NO.24143-17-7) is heated to decomposition, it emits toxic fumes of Cl− and NOx.